Kidney Failure, Chronic Clinical Trial
Official title:
Using Bioimpedance Analysis and Blood Volume Monitoring to Assess the Impact of Intradialytic Exercise
The purpose of this study is to examine the impact of exercise during dialysis using objective measures of fluid status determination, specifically bioimpedance analysis (BIA) and blood volume monitoring (BVM). We hypothesize that exercise during dialysis will be associated with more stable blood pressures and that this will be reflected in different output from BIA and BVM monitoring.
Achieving dry weight (DW) is essential for the optimal health of dialysis patients. Despite
being one of the most basic and important factors in the management of hemodialysis
patients, there are many obstacles to achieving DW. One problem underlying optimal fluid
status management lies in the clinical assessment used to determine DW. The current standard
is clinical judgment which is often reactive (ie. setting a weight below which the patient
develops hypotension or cramping) instead of goal directed (ie. trying to achieve defined
target measures). Moreover, DW is a dynamic parameter that changes in patients over time,
and ongoing assessment remains reactive to changes in clinical status instead of proactively
based on monitoring of validated measures. A primary impediment to achieving DW is the
relatively short time during dialysis limiting vascular refilling and leading to
complications of hypotension and other adverse sequelae of relatively rapid volume removal.
The evaluation of interventions aimed at improving symptoms and preventing complications
will be scientifically strengthened by objective assessment of the patient's volume.
Fortunately two objective clinically validated tools to assess volume status have emerged:
bioimpedance (BIA) which allows assessment of the patient's hydration status and blood
volume monitoring (BVM) which allows direct measure of the rate of vascular refilling during
dialysis. These will be essential in understanding the impact of therapeutic interventions
directed at improving achievement of DW.
The next important consideration is selecting an intervention that shows promise in
assisting patients in achieving DW. While many interventions deserve careful analysis we
select exercise because of the additional cardiovascular benefits of exercise, and it fits
into our outpatient program as part of achieving our overall outpatient wellness objectives.
To this end we propose the following specific aim:
Specific Aim: Systematically evaluate the effects of exercise on hemodynamic stability and
achievement of dry weight by testing the following hypotheses.
Hypothesis 1: Exercise bike riding during dialysis improves vascular refilling as determined
by BVM.
Hypothesis 2: Exercise bike riding during dialysis improves (leads to a reduction in) tissue
hydration status as determined by BIA.
Hypothesis 3: Improved intra-dialytic blood pressure stability is directly related to
improved vascular refilling as assessed by BVM, which is in turn related to improved
(reduced) tissue hydration as assessed by BIA.
Hypothesis 4: Intravascular refilling (assessed by BVM) is directly related to reduction in
tissue hydration (assess by BIA).
;
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03246984 -
VALUE- Vascular Access Laminate eUropean Experience. A Post Market Surveillance Study to Assess the Safety and Effectiveness of VasQ
|
N/A | |
Completed |
NCT02922361 -
Spending and Outcomes for Complex Medicare Advantage Patients
|
||
Completed |
NCT02235571 -
iChoose Decision Kidney Aid for End-Stage Renal Disease Patients
|
N/A | |
Completed |
NCT01933789 -
Improving Communication About Serious Illness
|
N/A | |
Completed |
NCT01930396 -
Use of Tinzaparin for Anticoagulation in Hemodialysis
|
Phase 4 | |
Completed |
NCT01922843 -
A Phase 2 Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism in Patients on Hemodialysis
|
Phase 2 | |
Not yet recruiting |
NCT01674660 -
Factors Associated With Interdialytic Blood Pressure Variability in Maintenance Hemodialysis Patients
|
N/A | |
Completed |
NCT01209403 -
Insulin-like Growth Factor (IGF-I) in Hemodialysis Patients
|
Phase 4 | |
Not yet recruiting |
NCT01157260 -
The Effects of AST-120 on Endothelial Dysfunction in Patients With Chronic Kidney Disease
|
Phase 4 | |
Completed |
NCT00753116 -
Renal Denervation in End Stage Renal Disease Patients With Refractory Hypertension
|
Phase 1 | |
Recruiting |
NCT00532688 -
N-Acetylcysteine in Heart Failure With Coexistent Chronic Renal Failure
|
Phase 2/Phase 3 | |
Completed |
NCT00528788 -
How Vitamin D Analogues Affect Endothelial Cells in Patients on Dialysis
|
Phase 4 | |
Completed |
NCT00534144 -
Comparison Between Effects of Two Iron Preparations on Protein in the Urine
|
Phase 1 | |
Completed |
NCT00226902 -
Vascular Reactivity in Kidney Disease Patients
|
N/A | |
Completed |
NCT00382044 -
Audit of the Effect of Changing From IV to SC Administration of ESA's in Haemodialysis Patients
|
N/A | |
Recruiting |
NCT00235287 -
Pulse Wave Velocity, Pulse Wave Morphology and Blocking of the Reninangiotensin System in Patients With Chronic Kidney Disease
|
Phase 4 | |
Completed |
NCT00224081 -
DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
|
Phase 4 | |
Completed |
NCT00071214 -
Study to Evaluate the Effectiveness of StaphVAX in Adults on Hemodialysis
|
Phase 3 | |
Completed |
NCT00049907 -
Cardiac and Renal Disease Study (CARDS)
|
N/A | |
Completed |
NCT00006297 -
Risk Factors for CV Disease in a Dialysis Cohort
|
N/A |